Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics

  • Juan Casado-Vela
  • Arancha Cebrián
  • María Teresa Gómez del Pulgar
  • Juan Carlos Lacal
Educational Series/Red Series Current Technology in Cancer Research and Treatment

DOI: 10.1007/s12094-011-0707-9

Cite this article as:
Casado-Vela, J., Cebrián, A., Gómez del Pulgar, M.T. et al. Clin Transl Oncol (2011) 13: 617. doi:10.1007/s12094-011-0707-9

Abstract

Recent technological advances, combined with the development of bioinformatic tools, allow us to better address biological questions combining -omic approaches (i.e., genomics, metabolomics and proteomics). This novel comprehensive perspective addresses the identification, characterisation and quantitation of the whole repertoire of genes, proteins and metabolites occurring in living organisms. Here we provide an overview of recent significant advances and technologies used in genomics, metabolomics and proteomics. We also underline the importance and limits of mass accuracy in mass spectrometry-based -omics and briefly describe emerging types of fragmentation used in mass spectrometry. The range of instruments and techniques used to address the study of each -omic approach, which provide vast amounts of information (usually termed ‘high-throughput’ technologies in the literature) is briefly discussed, including names, links and descriptions of the main databases, data repositories and resources used. Integration of multiple -omic results and procedures seems necessary. Therefore, an emerging challenge is the integration of the huge amount of data generated and the standardisation of the procedures and methods used. Functional data integration will lead to answers to unsolved questions, hopefully, applicable to clinical practice and management of patients.

Keywords

Genomics Proteomics Metabolomics Bioinformatics 

Copyright information

© Feseo 2011

Authors and Affiliations

  • Juan Casado-Vela
    • 1
  • Arancha Cebrián
    • 1
  • María Teresa Gómez del Pulgar
    • 1
  • Juan Carlos Lacal
    • 1
  1. 1.Translational Oncology UnitInstituto de Investigaciones Biomédicas “Alberto Sols” Spanish National Research Council (CSIC-UAM)MadridSpain

Personalised recommendations